The EPO published patent EP3688134A1 on March 25, 2026, covering a system and method for producing biomolecules including viral vaccines. The patent application (EP3688134) names Univercells Technologies SA as applicant and is classified under IPC codes C12N 7/00 (viruses), C12M 1/00 (bioreactors), and C12M 1/26 (bioreactor components). The filing is designated for all European Patent Convention contracting states.

This is an informational patent publication and does not impose compliance obligations on third parties. Competitors developing similar viral vaccine production technologies should review the patent claims to assess potential licensing needs or freedom-to-operate considerations. No action is required for routine business operations.